Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Investigation of Microrna-10B Values for the Discrimination of Metastasis Due to Melanoma Publisher



Mokhtari M1 ; Rouhanizadeh N1 ; Hajialiasgar S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical and Anatomical Pathology, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Research in Medical Sciences Published:2021


Abstract

Background: Melanoma is one of the most invasive cutaneous cancers with characteristics such as rapid progression and distant metastasis. The early diagnosis and staging of melanoma can help better manage the patients. The current study is aimed to assess the values of microRNA-10b (miRNA-10b) in the discrimination of metastatic melanomas. Materials and Methods: The current cross-sectional study has been conducted on forty patients diagnosed with melanoma since 2011. Cell culture of melanoma cell lines derived from the cancerous tissue, including WM115, BLM, K1735, WM793, and A375M, was cultured. In order to assess miRNA-10b levels, the real-time polymerase chain reaction was utilized. The absence (n = 20)/presence (n = 20) of metastasis was diagnosed with chest computed tomography or chest X-ray. The values of miRNA-10b for the discrimination of metastasis incidence were assessed. Results: The demographic characteristics, including age and gender of the metastatic and nonmetastatic patients, were similar (P > 0.05). The specimen cultures were positive for miRNA-10b in 14 (35%) of the metastatic cases versus 4 (20%) of the nonmetastatic ones (P = 0.004). The quantitative analysis of miR-2b revealed significantly higher levels in metastatic cases (-1.59 ± 1.13 in metastatic vs.-0.16 ± 0.67 in nonmetastatic cases; P = 0.001). The measured area under the curve for the value of miRNA-10b was 0.923 (P < 0.001; 95% confidence interval: 0.811-1) with sensitivity and specificity of 100% and 94.4%. Conclusion: Based on this study, metastatic melanoma was associated with elevated levels of miRNA-10b. This marker had the sensitivity and specificity of 100% and 94.4% for the discrimination of metastatic melanoma from nonmetastatic ones. © 2022 Royal Society of Chemistry. All rights reserved.
Related Docs
View other Related Docs
1. Comparison of Mir-211 Expression in Murine Melanoma Cell Line and Murine Melanoma Tumor by Real-Time Polymerase Chain Reaction, Journal of Isfahan Medical School (2012)
2. Mir-370 Expression Analysis in Breast Cancer, Journal of Isfahan Medical School (2015)
3. The Role of Microrna-30A and Downstream Snail1 on the Growth and Metastasis of Melanoma Tumor, Iranian Journal of Basic Medical Sciences (2019)
4. The Association of Mir-451 and Mir-21 in Plasma With Lymph Node Metastases in Breast Cancer, Journal of Babol University of Medical Sciences (2018)
5. Emerging Role of Mir-372 and Mir-101A in Head and Neck Squamous Cell Carcinoma, Clinical Laboratory (2020)
6. Histopathological Characteristics of Cutaneous Melanoma in Isfahan, Iran, From 2013 to 2018, Journal of Skin Cancer (2022)
7. A Rapid and Simple Method for Simultaneous Determination of Three Breast Cancer Related Micrornas Based on Magnetic Nanoparticles Modified With S9.6 Antibody, Analytical Biochemistry (2023)
8. Evaluation of Mir-103 Expression in Peripheral Blood Mononuclear Cells of Type 2 Diabetic and Prediabetic Rats, Journal of Isfahan Medical School (2014)
Experts (# of related papers)
View all Related Experts
Rasoul Salehi (5)
Shaghayegh Haghjooy Javanmard (5)
Other Related Docs
9. The Therapeutic Potential of Human Adipose-Derived Mesenchymal Stem Cells Producing Cxcl10 in a Mouse Melanoma Lung Metastasis Model, Cancer Letters (2018)
10. The Role of Cancer-Associated Fibroblasts and Exosomal Mirnas-Mediated Intercellular Communication in the Tumor Microenvironment and the Biology of Carcinogenesis: A Systematic Review, Cell Death Discovery (2024)
11. Microrna-200C Overexpression in Cancer-Associated Fibroblasts Reduces the Invasive Properties of Breast Tumour Cells, Clinical and Translational Discovery (2022)
12. Therapeutic Inhibition of Microrna-21 (Mir-21) Using Locked-Nucleic Acid (Lna)-Anti-Mir and Its Effects on the Biological Behaviors of Melanoma Cancer Cells in Preclinical Studies, Cancer Cell International (2020)
13. Dysregulated Mir-103 and Mir-143 Expression in Peripheral Blood Mononuclear Cells From Induced Prediabetes and Type 2 Diabetes Rats, Gene (2015)
14. Differential Expression Profile of Mir-27B, Mir-29A, and Mir-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients, Molecular Therapy Oncolytics (2020)
15. Apoptosis-Inducing and Antiproliferative Effect by Inhibition of Mir-182-5P Through the Regulation of Casp9 Expression in Human Breast Cancer, Cancer Gene Therapy (2017)
16. Pbmcs: A New Source of Diagnostic and Prognostic Biomarkers, Archives of Physiology and Biochemistry (2022)
17. Long Non-Coding Rnas and Melanoma: From Diagnosis to Therapy, Pathology Research and Practice (2023)
18. Plasma Level of Mir-21 and Mir-451 in Primary and Recurrent Breast Cancer Patients, Breast Cancer: Targets and Therapy (2019)
19. Micro-Rnas As Critical Regulators of Matrix Metalloproteinases in Cancer, Journal of Cellular Biochemistry (2018)